Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Xiashuang Zhao"'
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 8, Pp 3417-3424 (2024)
According to previous studies, D-dimer levels are associated with the prognosis of patients with pancreatic cancer (PC). However, the results of current studies are limited and controversial. Therefore, we performed this meta-analysis to assess the r
Externí odkaz:
https://doaj.org/article/b4cb96bf7cd74c37b3d46a4f44fe1916
Autor:
Xiashuang Zhao, Yongfeng Wang, Xianglai Jiang, Bangqian Mo, Chenyu Wang, Mingzheng Tang, Yao Rong, Guiqian Zhang, Ming Hu, Hui Cai
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background The immunological checkpoint known as Inducible T Cell Costimulatory Factor (ICOS, Cluster of Differentiation, CD278) is activated and expressed on T cells. Both somatic cells and antigen-presenting cells expressed its ligand, ICO
Externí odkaz:
https://doaj.org/article/687bda4019164deaa1048ec2189188b2
Autor:
Bangqian Mo1,2,3,4, Xiashuang Zhao1,2,3,4, Yongfeng Wang2,3,4,5, Xianglai Jiang2,3,4,6, Deming Liu2,3,4, Hui Cai3,7,8 caialonteam@163.com
Publikováno v:
Oncologie (De Gruyter). Jan2023, Vol. 25 Issue 1, p17-35. 19p.
Autor:
Yao Rong, Yongfeng Wang, Mingzheng Tang, Guiqian Zhang, Yuan Yuan, Fengyuan Dong, Zhihang Wu, Guorong Ma, Songhua Liu, Xiashuang Zhao, Hui Cai
Publikováno v:
Analytical Cellular Pathology, Vol 2023 (2023)
Background. NKG2A (KLRC1) belongs to the NKG2 family, which has been shown to affect the activity of natural killer (NK) cells and CD8T cells. However, a comprehensive biological analysis and exploration of NKG2A in different cancers is lacking and t
Externí odkaz:
https://doaj.org/article/fc0fe15445044fb29206561c12ddc811
Autor:
Yao Rong, Fengyuan Dong, Guiqian Zhang, Mingzheng Tang, Xiashuang Zhao, Yan Zhang, Pengxian Tao, Hui Cai
Publikováno v:
PROTEOMICS – Clinical Applications. :2200102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7145cb8c02cd3cb4472b49a6809c7968
https://doi.org/10.1002/prca.202200102
https://doi.org/10.1002/prca.202200102
Autor:
Rong, Yao1,2,3,4 (AUTHOR), Wang, Yongfeng2,3,4,5 (AUTHOR), Tang, Mingzheng1,2,3,4 (AUTHOR), Zhang, Guiqian1,2,3,4 (AUTHOR), Yuan, Yuan6 (AUTHOR), Dong, Fengyuan7 (AUTHOR), Wu, Zhihang1 (AUTHOR), Ma, Guorong1 (AUTHOR), Liu, Songhua1,2 (AUTHOR), Zhao, Xiashuang1,2,3,4 (AUTHOR), Cai, Hui2,3,4,5 (AUTHOR)
Publikováno v:
Analytical Cellular Pathology: Cellular Oncology. 10/21/2023, p1-28. 28p.
Autor:
Zhao, Xiashuang1,2,3,4 (AUTHOR), Wang, Yongfeng2,3,4,5 (AUTHOR), Jiang, Xianglai2,6 (AUTHOR), Mo, Bangqian1,2 (AUTHOR), Wang, Chenyu6 (AUTHOR), Tang, Mingzheng1,2 (AUTHOR), Rong, Yao1,2 (AUTHOR), Zhang, Guiqian1,2 (AUTHOR), Hu, Ming7 (AUTHOR) 120220903131@lzu.edu.cn, Cai, Hui2,3,4,5,7 (AUTHOR) caialonteam@163.com
Publikováno v:
BMC Cancer. 2/28/2023, Vol. 23 Issue 1, p1-15. 15p.
Autor:
Rong, Yao, Dong, Fengyuan, Zhang, Guiqian, Tang, Mingzheng, Zhao, Xiashuang, Zhang, Yan, Tao, Pengxian, Cai, Hui
Publikováno v:
Proteomics - Clinical Applications; Sep2023, Vol. 17 Issue 5, p1-22, 22p
Publikováno v:
Immunotherapy Weekly; 4/25/2023, p283-283, 1p